We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Sequenom, Inc. (SQNM)
An SI Board Since January 2000
Posts SubjectMarks Bans Symbol
364 54 0 SQNM
Emcee:  Nav Toor Type:  Unmoderated
Sequenom seeks to shed light on the genetic underpinnings of life for uses in industrial genomics. Sequenom's MassArray technology uses mass spectrometry to analyze variations in DNA (the most common are called single nucleotide polymorphisms) to determine which ones have an impact on human health, agricultural yields, or livestock production. The company's Genolyzer software analyzes genotype samples. Its SpectroCHIP silicon wafers are used with the MassArray system to analyze biomolecules. Sequenom is beta testing its technology at Genzyme, the US Department of Agriculture, and the National Institutes of Health, among others. Sequenom is going to have its IPO this week. I think Sequenom has better technology than Affymetrix. Thus, I believe it will equal or surpass the valuation of Affymetrix.
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
364My cost basis for everything is probably around $3.30 so I'm a net loser of HenryMiller-7/28/2016
363Sold around 2/3 of my shares at $2.37 yesterday. Not sure why I haven't solTed Dreiser-7/28/2016
362And....the worms are coming out of the surprise.. one of several Savant-7/27/2016
361[X] $SQNM#Sequenom up 1.5193 (178.59%) stock nearly triples after buyout deal fSI Ron (Colonel Sammy)-7/27/2016
360I'm ready for a bounce back up, believe me, but the stock is not going anywhHenryMiller-7/14/2016
359Getting ready for the bounce back up. [graphic]hollyhunter-7/8/2016
358As a topic for a little discussion, what are the major holders thinking with SQNTed Dreiser-7/6/2016
357It's not a salve for our wounds, but if you look at the XBI, the index droppHenryMiller-7/3/2016
356I don't think BK is a concern. I think the company can reach breakeven as DiHenryMiller-7/1/2016
355HM, sharing your misery and cynicism regarding SQNM's marketing outreach. TTed Dreiser-7/1/2016
354Illumina, MolecularMD to Co-Develop Oncology Diagnostics
353SQNM marketing just sent me an email entitled: Your current NIPT doesn't knoHenryMiller-6/29/2016
352And that, as they say, is the end of that. SQNM's cert is denied. It's dHenryMiller-6/27/2016
351Here we go. SCOTUS will consider the case on Thursday. If they take the case, thHenryMiller-6/23/2016
350Yeah, I've been too lazy or disinterested to listen so far. Maybe I will, bTed Dreiser-6/14/2016
349I finally listened to the presentation today. Well, half-listened. I was workingHenryMiller-6/13/2016
348I didn't get a chance to listen to it. Was there any mention of the convertTed Dreiser-6/11/2016
347The latest presentation. Hard to see anything here to get excited about. Wake meHenryMiller-6/10/2016
346I totally understand wanting to trade around the position. I'm standing pat HenryMiller-6/8/2016
345Sold two small batches today, $1.10 and $1.13. Just to have a little dry powderTed Dreiser-6/7/2016
344Yay! More lawsuits. Just what we need. Now suing Ariosa in Australia. finance.HenryMiller-6/7/2016
343I wouldn't put too much stock in SCOTUS scheduling the case on any particulaHenryMiller-6/6/2016
342Sold a small amount, with a tiny profit, this morning at $1.01 to lighten my expTed Dreiser-6/6/2016
341Booted from B&T board for questioning the management and prospects for this Ted Dreiser-6/5/2016
340My average is in the low $3's. This has not been fun. I'm not sure theHenryMiller-6/5/2016
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):